CSIMarket


Surmodics Inc  (SRDX)
Other Ticker:  
 

Surmodics Inc

SRDX's Fundamental analysis








Looking into Surmodics Inc growth rates, revenue grew by 123.7 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 180

Medical Equipment & Supplies industry recorded growth of revenues by 5.39 %

Surmodics Inc realized net income compared to net loss a year ago in IV. Quarter 2023

More on SRDX's Growth


Surmodics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 22.49 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.59.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.03.


More on SRDX's Valuation
 
 Total Debt (Millions $) 29
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 423,158
 Net Income/Employee (TTM) $ -33,585
 Receivable Turnover (TTM) 12.3
 Tangible Book Value (Per Share $) 3.64

Surmodics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 22.49 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.59.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.03.

Surmodics Inc Price to Book Ratio is at 4 higher than Indusry Avg. of -619.15, and higher than S&P 500 Avg. of 0.01

More on SRDX's Valuation

  Market Capitalization (Millions $) 480
  Shares Outstanding (Millions) 14
  Employees 316
  Revenues (TTM) (Millions $) 134
  Net Income (TTM) (Millions $) -11
  Cash Flow (TTM) (Millions $) 21
  Capital Exp. (TTM) (Millions $) -3
  Total Debt (Millions $) 29
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 423,158
  Net Income/Employee(TTM) $ -33,585
  Receivable Turnover Ratio (TTM) 12.3
  Tangible Book Value (Per Share $) 3.64

  Market Capitalization (Millions $) 480
  Shares Outstanding (Millions) 14
  Employees 316
  Revenues (TTM) (Millions $) 134
  Net Income (TTM) (Millions $) -11
  Cash Flow (TTM) (Millions $) 21
  Capital Exp. (TTM) (Millions $) -3


    SRDX's Profitability Comparisons
Surmodics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 46.95 %.

Surmodics Inc net profit margin of 35.42 % is currently ranking no. 5 in Medical Equipment & Supplies industry, ranking no. 35 in Healthcare sector and number 300 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.62
  Total Debt to Equity (MRQ) 0.25
  Tangible Leverage Ratio (MRQ) 1.3
  Asset Turnover Ratio (TTM) 0.79
  Inventory Turnover Ratio (TTM) 1.91



Surmodics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 46.95 %.

Surmodics Inc net profit margin of 35.42 % is currently ranking no. 5 in Medical Equipment & Supplies industry, ranking no. 35 in Healthcare sector and number 300 in S&P 500.

More on SRDX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com